Why Vermillion's Stock Is Trading Higher Today

Vermillion, Inc. VRML shares were trading higher on Wednesday, after the company announced it completed validation of new pre-surgical test offerings with OVA1 plus, including coronavirus antibody testings.

The company is also expected to join the Russell 3000 Index on June 29.

Vermillion is a diagnostic service and bio-analytic solutions provider company. It is engaged in the business of developing and commercializing diagnostic tests for the gynecologic disease. The company's products include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor. It serves clinical reference laboratories, hospital laboratories, and physician offices. Geographically all the operations are functioned from the region of U.S.

Vermillion shares are trading up 7.13% at $4.81 at time of publication on Wednesday. The stock has a 52-week high of $5.78 and a 52-week low of 35 cents.